| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Chemistry | 918 | 8 | 11 | 6 |
Advanced Pharmaceutical Bulletin investigates areas of study like Pharmacology, Chromatography, Internal medicine, Nuclear chemistry and Drug delivery. Some problems in Pharmacology that were presented in Advanced Pharmaceutical Bulletin overlapped with concepts under Toxicity, Oxidative stress and Apoptosis. The journal addresses concerns in Apoptosis which are intertwined with other disciplines, such as Cancer research, Cell growth and Cytotoxicity.
Chromatography research presented in it encompasses a variety of subjects, including Solubility and Particle size. It explores topics in Particle size which can be helpful for research in disciplines like Nanoparticle and Zeta potential. Nanoparticle studies covered in Advanced Pharmaceutical Bulletin falls within the purview of Nanotechnology.
The journal focuses on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology and Diabetes mellitus, Endocrinology. Advanced Pharmaceutical Bulletin served as a forum through which researchers explored different topics like Nuclear chemistry and Differential scanning calorimetry.
The published articles focus on Pharmacology, Nanotechnology, Drug delivery, Nanoparticle and Chromatography. While the primary focus in the most cited papers is Drug delivery, they also dissect topics surrounding Drug and Transdermal as a whole. The works on Chromatography tackled in the most cited papers bring together disciplines like Solubility, In vivo and Particle size.
The journal primarily focuses on research topics in Pharmacology, Cancer research, Cancer, Mesenchymal stem cell and Apoptosis. The research on Pharmacology featured in Advanced Pharmaceutical Bulletin combines topics in other fields like Malondialdehyde, Blood–brain barrier, Liver X receptor, Drug target and Cytotoxicity. While work presented in it provided substantial information on Cancer research, it also covered topics in Cancer cell, Breast cancer and Downregulation and upregulation.
Topics in Cancer explored in Advanced Pharmaceutical Bulletin were investigated in conjunction with research in Lung cancer, Disease, Chemotherapy and Bioinformatics. It tackles research in MTT assay as part of the general discipline of Apoptosis, however, it also discusses concepts in Prostate cancer cell line. While Drug delivery is the focus of it, it also provided insights into the studies of Chitosan and Biomedical engineering.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Advanced Pharmaceutical Bulletin (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Advanced Pharmaceutical Bulletin (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 22.95% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 61.70% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.26% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 8.51% of all publications and 25.53% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Mehran Alavi;Mehran Alavi;Saeed Dehestaniathar;Shadieh Mohammadi;Afshin Maleki
(2020)Fatima Molavi;Hamed Hamishehkar;Ali Nokhodchi
(2020)Mehdi Hadjianfar;Dariush Semnani;Jaleh Varshosaz;Sajad Mohammadi
(2021)Sahar Yazdani Ashtiani;Saman Ahmad Nasrollahi;Atefeh Naeimifar;Aubid Nassiri Kashani
(2020)Elahehnaz Parhizkar;Delaram Sadeghinia;Hamed Hamishehkar;Shadi Yaqoubi
(2021)Mohammad Yousefi;Seid Mahdi Jafari;Hossein Ahangari;Ali Ehsani
(2021)For students interested in Chemistry, exploring diverse career paths can open many doors. One option is to pursue a 6 year pharmd programs, which accelerate your journey to becoming a Doctor of Pharmacy. These programs combine undergraduate and professional studies, allowing you to enter the pharmaceutical field faster.
Graduates with a strong chemistry background may also consider becoming a pharmacist, a role that requires specialized education and offers rewarding opportunities. To understand the steps involved and what you can expect financially, check out the guide on how to become a pharmacist salary.
If you are interested in the business side of pharmaceuticals, becoming a pharmaceutical sales representative is another viable option. This career path highlights not only product knowledge but also communication skills, with insights on typical pharma sales rep salary and career growth.
For those interested in healthcare administration, obtaining certification as a professional coder can complement a chemistry degree. Learn more about the certification process, potential earnings, and job outlook at the page about cpc.
